Skip to main content
SpringerLink
Log in

Lower gastrointestinal bleeding in a patient with Crohn’s disease and plasma cell leukemia in remission

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Szelenyi H, Kreuser ED, Keilholz U et al (2001) Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effective therapy for patients with advanced multiple myeloma. Ann Oncol 12:105–108

    Article  CAS  PubMed  Google Scholar 

  2. Knop S, Gerecke C, Liebisch P et al (2009) Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom). Blood 113:4137–4143

    Article  CAS  PubMed  Google Scholar 

  3. Montefusco V, Galli M, Spina F et al (2014) Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide. Leuk Lymphoma 55:2032–2037

    Article  CAS  PubMed  Google Scholar 

  4. Musto P, Pagano L, Petrucci MT et al (2012) Primary plasma cell leukemia in the era of new drugs: has something changed? Crit Rev Oncol Hematol 82:141–149

    Article  PubMed  Google Scholar 

  5. van de Donk NW, Lokhorst HM, Anderson KC, Richardson PG (2012) How I treat plasma cell leukemia. Blood 120:2376–2389

    Article  PubMed Central  PubMed  Google Scholar 

  6. Varettoni M, Corso A, Pica G et al (2010) Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 21:325–330

    Article  CAS  PubMed  Google Scholar 

  7. Deng S, Xu Y, An G et al. (2015) Features of extramedullary disease of multiple myeloma: high frequency of P53 deletion and poor SURVIVAL: a retrospective single-center study of 834 cases. Clin Lymphoma Myeloma Leuk

  8. Rogulj IM, Acamovic B, Filipec-Kanizaj T et al (2011) Extramedullary multiple myeloma of the colon—case presentation and literature review. Acta Med Croatica 65(Suppl 1):167–171

    PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin II (Abteilung Hämatologie und Internistische Onkologie), Universitätsklinikum Jena, Jena, Germany

    Karin G. Schrenk, Lars-Olof Mügge, Andreas Hochhaus & Sebastian Scholl

  2. Institut für Pathologie, Universitätsklinikum Jena, Jena, Germany

    Kathrin Katenkamp

  3. Klinik für Innere Medizin IV (Gastroenterologie, Hepatologie und Infektiologie), Universitätsklinikum Jena, Jena, Germany

    Jörg Felber

  4. Department of Internal Medicine II, Erlanger Allee 101, 07740, Jena, Germany

    Sebastian Scholl

Authors
  1. Karin G. Schrenk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathrin Katenkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jörg Felber
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars-Olof Mügge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Hochhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sebastian Scholl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Scholl.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schrenk, K.G., Katenkamp, K., Felber, J. et al. Lower gastrointestinal bleeding in a patient with Crohn’s disease and plasma cell leukemia in remission. Ann Hematol 94, 2063–2065 (2015). https://doi.org/10.1007/s00277-015-2469-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2469-x

Keywords

Search

Navigation